 Diabetic Nephropathies
"Diabetic Nephropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Descriptor ID |
D003928
|
| MeSH Number(s) |
C12.777.419.192 C13.351.968.419.192 C19.246.099.875
|
| Concept/Terms |
Diabetic Nephropathies- Diabetic Nephropathies
- Nephropathies, Diabetic
- Nephropathy, Diabetic
- Diabetic Nephropathy
- Diabetic Kidney Disease
- Diabetic Kidney Diseases
- Kidney Disease, Diabetic
- Kidney Diseases, Diabetic
Diabetic Glomerulosclerosis- Diabetic Glomerulosclerosis
- Kimmelstiel-Wilson Syndrome
- Kimmelstiel Wilson Syndrome
- Syndrome, Kimmelstiel-Wilson
- Kimmelstiel-Wilson Disease
- Kimmelstiel Wilson Disease
- Nodular Glomerulosclerosis
- Glomerulosclerosis, Nodular
- Glomerulosclerosis, Diabetic
- Intracapillary Glomerulosclerosis
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Nephropathies".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Nephropathies".
This graph shows the total number of publications written about "Diabetic Nephropathies" by people in this website by year, and whether "Diabetic Nephropathies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 1 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 0 | 3 | 3 | | 2005 | 0 | 1 | 1 | | 2006 | 3 | 0 | 3 | | 2007 | 1 | 1 | 2 | | 2008 | 2 | 0 | 2 | | 2009 | 3 | 3 | 6 | | 2010 | 4 | 3 | 7 | | 2011 | 2 | 2 | 4 | | 2012 | 3 | 0 | 3 | | 2013 | 4 | 0 | 4 | | 2014 | 9 | 2 | 11 | | 2015 | 8 | 0 | 8 | | 2016 | 7 | 1 | 8 | | 2017 | 7 | 1 | 8 | | 2018 | 10 | 5 | 15 | | 2019 | 10 | 3 | 13 | | 2020 | 13 | 3 | 16 | | 2021 | 6 | 1 | 7 | | 2022 | 13 | 0 | 13 | | 2023 | 6 | 0 | 6 | | 2024 | 6 | 3 | 9 | | 2025 | 5 | 3 | 8 | | 2026 | 11 | 1 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetic Nephropathies" by people in Profiles.
-
Bjornstad P, Choi YJ, Narongkiatikhun P, Karihaloo A, Prasad PV, Li LP, Tommerdahl KL, Sethi M, Ramesh S, Birznieks C, Clarke A, Elia Y, Curtis J, Clarson C, Weissenkampen D, D'Antonio M, Pinzon Cortes JA, Hampson H, Yuan L, van Eeghen SA, Kanter JE, Bornfeldt KE, Vaisar T, Ladd P, Heerspink HJL, de Boer IH, Goodrich JA, Street K, Tuttle KR, Bergmann KR, Smith C, Hodgin JB, Schaub JA, Nair V, Menon R, Naik AS, McCown PJ, AlAkwaa F, Eddy S, Otto E, Kim NH, Nelson RG, Puelles VG, van Raalte DH, Cherney DZI, Pyle L, Mahmud FH, Kretzler M. SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes. Sci Transl Med. 2026 Jul 22; 18(859):eaee1005.
-
Liu JJ, Liu S, de Keizer J, Zheng H, Lee J, Javaugue V, Gurung RL, Ang K, Potier L, Nelson RG, Kestenbaum B, Bjornstad P, Lim SC, Hadjadj S, Saulnier PJ. Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes. Nephrol Dial Transplant. 2026 Jun 30; 41(7):1304-1312.
-
Pinzon Cortes JA, Narongkiatikhun P, Fuhri Snethlage CM, Del Castillo D, Tommerdahl KL, Nadeau KJ, Bjornstad P. Beyond Glycemia in T1D: The Hidden Burden of Insulin Resistance and Cardiorenal Risk in Type 1 Diabetes-Part 1. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):395-405.
-
van Heugten MH, Beckmann SB, Salib M, Curovic VR, Beernink JM, Faivre A, Laverman GD, Wu Q, Bjornstad P, Hall AM, Rossing P, Fenton RA, Heerspink HJL, Hoorn EJ. Distinct proteomic signatures of urinary extracellular vesicles link to albuminuria and treatment responses in diabetic kidney disease. Kidney Int. 2026 Aug; 110(2):438-450.
-
Menon R, Kimmel PL, Otto EA, Subramanian L, O'Connor CL, Godfrey B, Smith C, Alakwaa F, Berthier CC, Sarwal MM, Woodle ES, Pyle L, Choi YJ, Ladd P, Sedor JR, Rosas SE, Waikar SS, Naik AS, Melo Ferreira R, Eadon MT, Bitzer M, Bjornstad P, Hodgin JB, Kretzler M, Kpmp FTKPMP. Not all reference samples are equal in single-cell transcriptomics of human kidney tissue. JCI Insight. 2026 Jul 22; 11(14).
-
Melo Ferreira R, Gisch DL, Phillips CL, Cheng YH, Lucarelli N, Yennapureddy S, Asthana M, Lake BB, Bowen WS, Fang F, Asghari M, Sabo A, Barwinska D, Ferkowicz MJ, Toto RD, Sedor JR, Rosas SE, Bjornstad P, Hodgin JB, Alpers CE, Sarder P, Himmelfarb J, Schaub JA, Nair V, Winfree S, Sutton TA, Kelly KJ, Kretzler M, Jain S, El-Achkar TM, Dagher PC, Eadon MT. A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease. Kidney Int. 2026 Jul; 110(1):227-244.
-
Nair V, Minakawa A, Smith C, Berthier CC, Hartman J, Menon R, Fermin D, Otto EA, Gisch DL, Eadon MT, Jain S, Choi YJ, Pyle L, Eichinger F, Alakwaa FM, Rose MP, Subramanian L, El Saghir J, Beamish JA, Hodgin JB, Brosius FC, Bjornstad P, Nelson PJ, Harder JL, Werner T, Kretzler M, Schaub JA. Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition. Signal Transduct Target Ther. 2026 Apr 21; 11(1).
-
Rønn PF, Svensson J, Wibaek R, Dabelea D, Hulman A. HbA1c trajectories and risk of albuminuria in children and adolescents with type 1 diabetes followed into adulthood - a joint modeling approach of Danish nationwide register data. J Diabetes Complications. 2026 May; 40(5):109317.
-
Mottl AK, Sawinski DL, Bjornstad P. Kidney and Cardiovascular Protection in Diabetes: Beyond Diabetes Typology. Am J Kidney Dis. 2026 May; 87(5):730-739.
-
Simonsen JR, Gordin D, Januszewski AS, Jenkins AJ, van Raalte DH, van Baar MJ, Bjornstad P, Thorn LM, Groop PH. A pilot study on measured insulin sensitivity and estimated glucose disposal rates in adults with type 1 diabetes and diabetic kidney disease. Endocrine. 2026 Feb 03; 91(1):61.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|